SpringWorks Therapeutics, Inc. financial data

Symbol
SWTX on Nasdaq
Location
100 Washington Boulevard, Stamford, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 9, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 522 % -33.9%
Quick Ratio 13.1 %
Debt-to-equity 16.7 % +3.67%
Return On Assets -43.8 % +23.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 75.3M shares +1.67%
Common Stock, Shares, Outstanding 75M shares +1.25%
Entity Public Float 2.75B USD +71.6%
Common Stock, Value, Issued 8K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 74.9M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 74.9M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.3M USD
Research and Development Expense 196M USD +15.2%
General and Administrative Expense 178M USD +47.9%
Costs and Expenses 130M USD +12.8%
Operating Income (Loss) -265M USD +26.3%
Nonoperating Income (Expense) 17.4M USD -30.2%
Net Income (Loss) Attributable to Parent -254M USD +25.1%
Earnings Per Share, Basic -3 USD/shares +33.8%
Earnings Per Share, Diluted -3 USD/shares +33.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.8M USD -46%
Cash, Cash Equivalents, and Short-term Investments 383M USD -33.2%
Accounts Receivable, after Allowance for Credit Loss, Current 40.3M USD +160%
Inventory, Net 12.4M USD +138%
Assets, Current 356M USD -24.5%
Property, Plant and Equipment, Net 19.3M USD +5.4%
Operating Lease, Right-of-Use Asset 6.58M USD +13.1%
Other Assets, Noncurrent 27.8M USD +88.2%
Assets 505M USD -23.1%
Accounts Payable, Current 14.9M USD +113%
Employee-related Liabilities, Current 15.6M USD -8.91%
Accrued Liabilities, Current 65.6M USD +16.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 82.3M USD +19.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 5.69M USD +2.01%
Liabilities 88M USD -1.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 442K USD
Retained Earnings (Accumulated Deficit) -1.24B USD -25.8%
Stockholders' Equity Attributable to Parent 417M USD -26.4%
Liabilities and Equity 505M USD -23.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -68.8M USD +12.9%
Net Cash Provided by (Used in) Financing Activities -10.6M USD -1822%
Net Cash Provided by (Used in) Investing Activities 73.4M USD +242%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 75.6M shares +1.73%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.98M USD +89.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 64.4M USD -45.7%
Deferred Tax Assets, Valuation Allowance 289M USD +27.3%
Deferred Tax Assets, Gross 293M USD +27.7%
Operating Lease, Liability 7.91M USD +12.1%
Depreciation 253K USD +134%
Payments to Acquire Property, Plant, and Equipment 30K USD -94.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -253M USD +25.3%
Lessee, Operating Lease, Liability, to be Paid 9.07M USD +12.9%
Property, Plant and Equipment, Gross 25.1M USD +21.7%
Operating Lease, Liability, Current 1.7M USD +73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.27M USD +13.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.25M USD +52.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.15M USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.18M USD +8.64%
Deferred Tax Assets, Operating Loss Carryforwards 147M USD +21.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.38M USD -27.4%
Additional Paid in Capital 1.68B USD +7.57%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.1M USD +51%
Share-based Payment Arrangement, Expense 109M USD +6.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%